Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Potent Immune Modulation by MEDI6383, an Engineered Human OX40 Ligand IgG4P Fc Fusion Protein.

Oberst MD, Augé C, Morris C, Kentner S, Mulgrew K, McGlinchey K, Hair J, Hanabuchi S, Du Q, Damschroder M, Feng H, Eck S, Buss N, de Haan L, Pierce AJ, Park H, Sylwester A, Axthelm MK, Picker L, Morris NP, Weinberg A, Hammond SA.

Mol Cancer Ther. 2018 May;17(5):1024-1038. doi: 10.1158/1535-7163.MCT-17-0200. Epub 2018 Mar 15.

2.

Mobilization of CD4+ T lymphocytes in inflamed mucosa reduces pain in colitis mice: toward a vaccinal strategy to alleviate inflammatory visceral pain.

Basso L, Boué J, Augé C, Deraison C, Blanpied C, Cenac N, Lluel P, Vergnolle N, Dietrich G.

Pain. 2018 Feb;159(2):331-341. doi: 10.1097/j.pain.0000000000001103.

PMID:
29140925
3.

A DBS method for quantitation of the new oral trypanocidal drug fexinidazole and its active metabolites.

Filali-Ansary A, Augé C, Abgrall A, Souchaud M, Pellissier F, Mordt OV, Blesson S, Sanderink GJ.

Bioanalysis. 2016 Oct;8(19):2045-63. doi: 10.4155/bio-2016-0110. Epub 2016 Sep 9.

PMID:
27611920
4.

Serge David: 1921-2014.

Bonnaffé D, Augé C, Augé J, David-Mabille C.

Adv Carbohydr Chem Biochem. 2014;71:2-8. No abstract available.

PMID:
25626187
5.

Building of a composite virtual slide from contiguous tissue samples.

Plancoulaine B, Oger M, Elie N, Belhomme P, Herlin P, Nasri A, Augé C, Brécin M, Marnay J, Bor-Angelier C.

Diagn Pathol. 2014;9 Suppl 1:S9. doi: 10.1186/1746-1596-9-S1-S9. Epub 2014 Dec 19.

6.

Screening for active tuberculosis in high-risk groups.

Jiménez-Fuentes MA, Augé CM, Gómez MN, Peiró JS, de Souza Galvao ML, Maldonado J, Molina-Pinargote I, Orcau A, Cayla JA.

Int J Tuberc Lung Dis. 2014 Dec;18(12):1459-65. doi: 10.5588/ijtld.14.0271.

PMID:
25517812
7.

Relevance of the cyclophosphamide-induced cystitis model for pharmacological studies targeting inflammation and pain of the bladder.

Augé C, Chene G, Dubourdeau M, Desoubzdanne D, Corman B, Palea S, Lluel P, Vergnolle N, Coelho AM.

Eur J Pharmacol. 2013 May 5;707(1-3):32-40. doi: 10.1016/j.ejphar.2013.03.008. Epub 2013 Mar 26.

PMID:
23541724
8.

[Information for patients about hospital infections in psychiatry: An assessment of healthcare professionals' knowledge, opinion and attitude].

Audureau E, Merle V, Kerleau K, Dollois B, Baugé-Rousseau M, Théry S, Tavolacci MP, Dubreuil N, Thillard D, Gasparin-Grisel S, Mathieu M, Augé C, Czernichow P; le réseau CoCLINNOR.

Encephale. 2010 Apr;36(2):132-8. doi: 10.1016/j.encep.2009.06.003. Epub 2009 Sep 23. French.

PMID:
20434630
9.

The steroid receptor RNA activator protein is recruited to promoter regions and acts as a transcriptional repressor.

Chooniedass-Kothari S, Hamedani MK, Auge C, Wang X, Carascossa S, Yan Y, Cooper C, Vincett D, Myal Y, Jalaguier S, Cavailles V, Leygue E.

FEBS Lett. 2010 Jun 3;584(11):2218-24. doi: 10.1016/j.febslet.2010.04.022. Epub 2010 Apr 14.

10.

Thrombin receptor: An endogenous inhibitor of inflammatory pain, activating opioid pathways.

Martin L, Augé C, Boué J, Buresi MC, Chapman K, Asfaha S, Andrade-Gordon P, Steinhoff M, Cenac N, Dietrich G, Vergnolle N.

Pain. 2009 Nov;146(1-2):121-9. doi: 10.1016/j.pain.2009.07.016. Epub 2009 Aug 11.

PMID:
19674841
11.

Protease-activated receptor-4 (PAR 4): a role as inhibitor of visceral pain and hypersensitivity.

Augé C, Balz-Hara D, Steinhoff M, Vergnolle N, Cenac N.

Neurogastroenterol Motil. 2009 Nov;21(11):1189-e107. doi: 10.1111/j.1365-2982.2009.01310.x. Epub 2009 Apr 20.

PMID:
19413681
12.

Exploring specificity of glycosyltransferases: synthesis of new sugar nucleotide related molecules as putative donor substrates.

Khaled A, Piotrowska O, Dominiak K, Augé C.

Carbohydr Res. 2008 Feb 4;343(2):167-78. Epub 2007 Nov 17.

PMID:
18048019
13.

Development of a ready-to-use antibiotic conservation solution for arterio-venous grafts.

Augé C, Gourdier B, Reiter-Chenel V, Rey JB.

PDA J Pharm Sci Technol. 2006 May-Jun;60(3):182-90.

PMID:
17089687
14.

Non-isosteric C-glycosyl analogues of natural nucleotide diphosphate sugars as glycosyltransferase inhibitors.

Vidal S, Bruyère I, Malleron A, Augé C, Praly JP.

Bioorg Med Chem. 2006 Nov 1;14(21):7293-301. Epub 2006 Jul 14.

PMID:
16843664
15.
16.

Predominant type 1 CMV-specific memory T-helper response in humans: evidence for gender differences in cytokine secretion.

Villacres MC, Longmate J, Auge C, Diamond DJ.

Hum Immunol. 2004 May;65(5):476-85.

PMID:
15172447
17.

Enzymatic supported synthesis of lacto-N-neotetraose using dendrimeric polyethylene glycol.

Renaudie L, Daniellou R, Augé C, Le Narvor C.

Carbohydr Res. 2004 Feb 25;339(3):693-8.

PMID:
15013407
18.

Structure-function analysis of the human sialyltransferase ST3Gal I: role of n-glycosylation and a novel conserved sialylmotif.

Jeanneau C, Chazalet V, Augé C, Soumpasis DM, Harduin-Lepers A, Delannoy P, Imberty A, Breton C.

J Biol Chem. 2004 Apr 2;279(14):13461-8. Epub 2004 Jan 13.

19.
20.

Relevance of peptide avidity to the T cell receptor for cytomegalovirus-specific ex vivo CD8 T cell cytotoxicity.

Villacres MC, Lacey SF, Auge C, Longmate J, Leedom JM, Diamond DJ.

J Infect Dis. 2003 Sep 15;188(6):908-18. Epub 2003 Sep 9.

PMID:
12964124
21.

Chemo-enzymatic synthesis of a divalent sialyl Lewis(x) ligand with restricted flexibility.

Bintein F, Augé C, Lubineau A.

Carbohydr Res. 2003 May 23;338(11):1163-73.

PMID:
12747858
22.

Recombinant (2-->3)-alpha-sialyltransferase immobilized on nickel-agarose for preparative synthesis of sialyl Lewis(x) and Lewis(a) precursor oligosaccharides.

Ivannikova T, Bintein F, Malleron A, Juliant S, Cerutti M, Harduin-Lepers A, Delannoy P, Augé C, Lubineau A.

Carbohydr Res. 2003 May 23;338(11):1153-61.

PMID:
12747857
23.

Intranasal administration of a synthetic lipopeptide without adjuvant induces systemic immune responses.

BenMohamed L, Krishnan R, Auge C, Primus JF, Diamond DJ.

Immunology. 2002 May;106(1):113-21.

24.

Human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy maintain activated CD8+ T cell subsets as a strong adaptive immune response to cytomegalovirus.

Villacres MC, Lacey SF, La Rosa C, Krishnan R, Auge C, Longmate J, Zaia JA, Leedom JM, Diamond DJ.

J Infect Dis. 2001 Aug 1;184(3):256-67. Epub 2001 Jul 10.

PMID:
11443550
25.

Exploring the acceptor substrate recognition of the human beta-galactoside alpha 2,6-sialyltransferase.

Legaigneur P, Breton C, El Battari A, Guillemot JC, Auge C, Malissard M, Berger EG, Ronin C.

J Biol Chem. 2001 Jun 15;276(24):21608-17. Epub 2001 Feb 20.

26.

Cloning, expression and gene organization of a human Neu5Ac alpha 2-3Gal beta 1-3GalNAc alpha 2,6-sialyltransferase: hST6GalNAcIV.

Harduin-Lepers A, Stokes DC, Steelant WF, Samyn-Petit B, Krzewinski-Recchi MA, Vallejo-Ruiz V, Zanetta JP, Augé C, Delannoy P.

Biochem J. 2000 Nov 15;352 Pt 1:37-48.

27.

The acceptor and site specificity of alpha 3-fucosyltransferase V. High reactivity of the proximal and low of the distal galbeta 1-4GlcNAc unit in i-type polylactosamines.

Pykäri M, Toivonen S, Natunen J, Niemela R, Salminen H, Aitio O, Ekström M, Parmanne P, Välimäki M, Alais J, Augé C, Lowe JB, Renkonen O, Renkonen R.

J Biol Chem. 2000 Dec 22;275(51):40057-63.

28.

Induction of CTL response by a minimal epitope vaccine in HLA A*0201/DR1 transgenic mice: dependence on HLA class II restricted T(H) response.

BenMohamed L, Krishnan R, Longmate J, Auge C, Low L, Primus J, Diamond DJ.

Hum Immunol. 2000 Aug;61(8):764-79.

PMID:
10980387
29.

[Oligosaccharide sulfate inhibitors of selectin-sugar interactions in inflammatory processes].

Auge C, Dagron F, Lemoine R, Le Narvor C, Lubineau A.

Ann Pharm Fr. 1999 May;57(3):216-22. Review. French.

PMID:
10427856
30.

Chemoenzymatic synthesis of a 3IV,6III-disulfated Lewis(x) pentasaccharide, a candidate ligand for human L-selectin.

Lubineau A, Augé C, Le Goff N, Le Narvor C.

Carbohydr Res. 1997 Dec;305(3-4):501-9.

PMID:
9648267
31.

Chemoenzymatic synthesis of carbohydrates.

Augé C, Crout DH.

Carbohydr Res. 1997 Dec;305(3-4):307-12. No abstract available.

PMID:
9648253
33.

Ergot alkaloid glycosides with immunomodulatory activities.

Kren V, Fiserová A, Augé C, Sedmera P, Havlícek V, Síma P.

Bioorg Med Chem. 1996 Jun;4(6):869-76.

PMID:
8818236
34.
35.

Professor Serge David.

Lubineau A, Auge C.

Carbohydr Res. 1992 Apr 10;228(1):vii-ix. No abstract available.

PMID:
1516078
37.

Enzymic methods in preparative carbohydrate chemistry.

David S, Augé C, Gautheron C.

Adv Carbohydr Chem Biochem. 1991;49:175-237. Review. No abstract available.

PMID:
1814172
38.

The use of immobilised glycosyltransferases in the synthesis of sialyloligosaccharides.

Augé C, Fernandez-Fernandez R, Gautheron C.

Carbohydr Res. 1990 Apr 25;200:257-68.

PMID:
2379208
39.
41.

[Double antibacterial therapy in untreated tuberculosis. Retrospective study of 120 unselected patients treated between 1972 and 1974].

Augé C, Lecocguic Y, Touaty E, Bussi S, Pariente R.

Rev Fr Mal Respir. 1982;10(6):391-9. French. No abstract available.

PMID:
6819611
42.

[Effect of non-ionizing electromagnetic waves on the viability and heredity of mammalian cells in established culture].

Gillois M, Auge C, Chevalet C.

Reprod Nutr Dev. 1980;20(6):1767-79. French. No abstract available.

PMID:
7349510
43.

Stannylene derivatives in glycoside synthesis. Application to the synthesis of the blood-group B antigenic determinant.

Augé C, Veyrières A.

J Chem Soc Perkin 1. 1979;7:1825-32. No abstract available.

PMID:
95118
44.

Blood group I activities of synthetic oligosaccharides assessed by radioimmunoassay.

Feizi T, Wood E, Augé C, David S, Veyrières A.

Immunochemistry. 1978 Nov;15(10-11):733-6. No abstract available.

PMID:
748174
45.
46.

[Ribonucleotide reductase from a mammalian rat tumor (Zajdela's hepatoma): stereospecificity of the reduction].

Augé C, David S, Zajdela F.

C R Acad Sci Hebd Seances Acad Sci D. 1972 Nov 6;275(19):2187-90. French. No abstract available.

PMID:
4346142

Supplemental Content

Support Center